{"chunk_id": "medquad__chunk_46870", "source": "medquad", "text": "Because limited information exists about the risks of long-term, low-dose cabergoline use, doctors generally prescribe the lowest effective dose and periodically reassess the need for continuing therapy. People taking cabergoline who develop symptoms of shortness of breath or swelling of the feet should promptly notify their physician because these may be signs of heart valve damage.\n                \nSurgery\n                \nSurgery to remove all or part of the tumor should only be considered if"}